Álvarez-López F, Gómez-Cruz ÁJ, Cruz-Miranda AL, Martínez- Villaseñor E, Alonzo-García CJ, González-Álvarez R, Díaz-Aceves PE, Alvarado-Rodríguez A, Rivera-Espíritu HJ, González-Ruiz R, Morel-Cerda EC

Language: Spanish
References: 29
Page: 137-142
PDF size: 599.35 Kb.

ABSTRACT

Introduction. Acute pancreatitis is defined as an inflammatory disease with inflammation as well as local and systemic complications. With an incidence of 10-50 cases per 100 000 inhabitants in the United States of America. There are multiple diagnostic and prognostic tools, including the determination of urinary trypsinogen-2.
Material and Methods. It is a prospective, analytical cohort study in patients with suspected acute pancreatitis. Age, sex, time of evolution, risk factors, APACHE II and etiology were evaluated, as well as serum levels of amylase, lipase, and trypsinogen-2 test in urine. The results were analyzed by SPSS.
Results. We found a good correlation of urinary trypsinogen-2 as a diagnostic test in patients with acute pancreatitis, but it does not seem to be a good prognostic marker of severity.
Discussion. The results were consistent with those published in literature, finding an association of urinary trypsinogen-2 as a diagnostic marker

REFERENCES

1. 1.Portelli M, Jones CD. Severe acute pancreatitis: pathogenesis, diagnosis and surgical management. Hepatobiliary Pancreat Dis Int 2017; 16: 155-159. 2.Conwell DL, Banks P, Greenberger NJ. Pancreatitis Aguda y Cronica. En: Kasper D, Fauci A, Hauser S, et al editores. Harrison Principios de Medicina Interna: volumen

2. 19ª edición. México, DF: McGraw-Hill Interamericana, 2016: 2090-2102.

3. 3.Van-Dijk SM, Hallensleben NDL, Van-Santvoort HC, Fockens P, Van Goor H, Bruno M, et al. Acute pancreatitis: recent advances through randomised trials. Gut 2017; 66: 2024-2032.

4. 4.Peery AF, Crockett SD, Barrit AS, Dellon ES, Eluri S, Gangarosa LM, et al. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology 2015; 149: 1731-1741.Ornelas R, Robles-Díaz G, Uscanga L. Classification of pancreatitis. Rev Invest Clin 1985; 37:71-72.

5. 5.Valdivieso-Herrera MA, Vargas-Ruiz LO, Arana- Chiang AR, Piscoya A. Situación Epidemiológica de la Pancreatitis Aguda en Latinoamérica y avances sobre el diagnóstico. Gastroenterología Latinoamericana; 2016: 46(2): 102-103.

6. 6.Dirección General de Coordinación de los Sistemas Nacionales Estadistico y de Información Geográfica, Secretaría de Salud y Seguridad Social. Estadísticas del Sector Salud y Seguridad Social 2003. Salud Pública de México 2004; 13-36

7. 7.Tenner S, Steinberg WM. Acute Pancreatitis. En: Feldman M, Friedman L, Brandt L, editores. Sleisenger And Fordtran's Gastrointestinal and Liver Disease: Pathophys i ology, Diagnosis and Management: vol.1. 9ª Ed. E.U.A: Saunders Elsevier, 2010: 959-983.

8. 8.Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis—2012: revision of Atlanta classification and definitions by international consensus. Gut 2013; 62: 102–11

9. 9.Chua TY, Walsh RM, Baker M, Stevens T. Necrotizing pancreatitis: Diagnose, treat, consult. Cleveland Clin J Med 2017;84:639-48.

10. 10.Tener S, Baillie J, DeWitt J, Swaroop Vege S. American College of Gastroenterology Guideline: Ma na gement of Ac ute Pa nc rea titis. Am J Gastroenterol, 2013: 1-16

11. 11.Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 2008; 57: 1698-1703

12. 12.Frey C, Zhou H, Harvey D, White Rh. Co-morbidity is a strong predictor of early death and multi-organ system failure among patients with acute pancreatitis. J Gastrointest Surg 2007; 11: 733-742.

13. 13.Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Díaz G, Pérez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 2006; 6: 206-209.

14. 14.Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Johannes RS, et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol 2009; 104: 966-971.

15. 15.Papachristou GI, Muddana V, Yadav D, O'Connell M, Sanders MK, Slivka A, et al. Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol 2010; 105: 435-441.

16. Lan kisch PA, Weber-Danny B, HebelK, Maisonneuve P, Lowenfels AB. The Harmless Acute Pancreatitis Score: A Clinical Algorithm for Rapid Initial Stratification of Nonserve Disease. Clin Gastroenterol Hepatol 2009; 7: 702-705

17. 17.Oskatsson V, Mehrabi M, Orsini N, Hammarqvist F, Segersvärd R, Andrén-Sandberg A. Validation of the Harmless Acute Pancreatitis Score in Predicting Nonserve Course of Acute Pancreatitis. Pancreatology 2011; 11: 464-468.

18. 18.Scott (Chino)

19. 19.Kamer E, Unalp HR, Derici H, Tansug T, Onal MA. Early diagnosis and prediction of severity in acute pancreatitis using the urinary trypsinogen-2 dipstick test: a prospective study. World J. Gastroenterol. 2007 Dec 14;13(46):6208-12.

20. 20.Hedström J, Korvuo A, Kenkimäki P, Tikanoja S, Haapiainen R, Kivilaakso E, et al. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet 1996; 16; 347(9003): 729-30.

21. 21.Mayumi T, Inui K, Maetani I, Yokoe M, Sakamoto T, Yoshida M, et al. Urinary Trypsinogen-2 Dipstick for Acute Pancreatitis Study Group of Japanese Society of Abdominal Emergency Medicine (UtrAP Study Group) Validity of the urinary trypsinogen-2 test in the diagnosis of acute pancreatitis. Pancreas. 2012 Aug; 41(6): 869-75.

22. 22.Andersen AM, Novovic S, Ersbøll AK, Jorgensen LN, Hansen MB. Urinary trypsinogen-2 dipstick in acute pancreatitis. Pancreas 2010; 39(1):26-30.

23. 23.Kemppainen EA, Hedström JI, Puolakkainen PA, Sainio VS, Haapiainen RK, Perhoniemi V, et al. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med 1997; 336(25): 1788-1793.

24. 24.Chang K, Lu W, Zhang K, Jia S, Li F, Wang F, et al. Rapid urinary trypsinogen-2 test in the early diagnosis of acute pancreatitis: a meta-analysis. Clin Biochem. 2012; 45(13-14): 1051-1056.

25. 25.Huang QL, Qian ZX, Li H. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis. Hepatogastroenterology 2010; 57(102- 103): 1295-1299.

26. 26.Lempinen M, Kylänpää-Bäck ML, Stenman UH, Puolakkainen P, Haapiainen R, Finne P, et al. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin Chem. 2001; 47(12): 2103-2107.

27. 27.González-González JA, Castañeda-Sepúlveda R, Martínez-Vázquez MA, García-Compean D, Flores- Rendón AR, Maldonado-GarzaHJ,et al. Características clínicas de la pancreatitis aguda en México. Revista de Gastroenterología de México 2012; 77(4): 167-173.

28. 28.Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144(6): 1252-61.

29. 29.Carroll JK, Heriick B, Gipson T, Lee SP. Acute pancreatitis: Diagnosis, prognosis, and treatment. Am Fam Physician 2007; 75: 1513-1520.